Not what you're looking for? Try a new search:
Hello, my name is Michael Vekasi, and I am honoured to be your incoming President of the Canadian Academy of Audiology (CAA). I look forward to serving you and our members in this role over the next year. I wanted to start my message off by saying a huge thank you to all members who…
Thank you to everyone who make the Canadian Academy of Audiology what it is Our e-publication, CanadianAudiologist.ca is now one decade old. With its previous incarnation, the Canadian Hearing Report, the Canadian Academy of Audiology has provided its members with cutting-edge articles and columns touching on all aspects of audiology. Given this special decade-anniversary, it…
Clinical management of adults who have unilateral hearing loss can be difficult. The challenge might be even more significant for adults with limited useable hearing unilaterally.
Vestibular sedatives can be prescribed to reduce acute onset vertigo after cochlear implantation, e.g., prochlorperazine, diphenhydramine and meclizine. Appropriate repositioning maneuver if BPPV is found. Vestibular rehabilitation is an effective intervention to improve overall balance, especially in cases of vestibular hypofunction.
In this edition of “Striking the Right Balance,” Erica Zaia, MSc, RAUD and Michael Vekasi, AuD, R.Aud, Aud(C), FAAA interview a patient presenting with dizziness and imbalance to look at how vestibular impairments negatively impact our patients’ quality of life and how our interactions with them contribute to their patient journey. This is the third article in this patient-focused series, featuring a patient diagnosed with concussion.
hearing aid manufacturers have begun to incorporate pupillometry and electrophysiology to evaluate the performance of their algorithms. These measures may be useful in verifying that algorithms designed to reduce hearing aid distortion effects are beneficial to the listener.
The long-awaited first results of the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) study were released on July 18, 2023. A brief description of the design and methods of the ACHIEVE study will be provided to highlight how the ACHIEVE study differs from previous research.
Advances in understanding cell death in the inner ear have opened the door for identifying investigational medicines that may prevent hearing loss. There is reason to be hopeful that additional medicines will successfully navigate the regulatory process and one day be available for patient populations.
Whilst many technical aspects of synchrotron imaging of the inner ear have been explored, we are not at the point of having a clinical imaging tool. However, if this does become a reality, it could provide a very useful diagnostic tool in audiology.
